Cargando…

Final Answer: Ghrelin Can Suppress Insulin Secretion in Humans, but Is It Clinically Relevant?

Detalles Bibliográficos
Autor principal:	Meyer, Christian
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963527/ https://www.ncbi.nlm.nih.gov/pubmed/20980471 http://dx.doi.org/10.2337/db10-1088

Ejemplares similares

Theoretically meaningful models can answer clinically relevant questions
por: Evans, Nathan J, et al.
Publicado: (2019)

Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans
por: Tong, Jenny, et al.
Publicado: (2010)

Commentary: Malignant Glaucoma - Have we finally found an answer?
por: Kaushik, Sushmita
Publicado: (2019)

Is Insulin Action in the Brain Clinically Relevant?
por: Filippi, Beatrice M., et al.
Publicado: (2012)

Hydrogen sulfide suppresses ghrelin secretion in vitro and delays postprandial ghrelin secretion while reducing appetite in mice
por: Slade, Erik, et al.
Publicado: (2018)

The D-Day of ghrelin
por: Tong, Jenny, et al.
Publicado: (2016)

Final questions, final answers
por: HAUSCHILD, Michael
Publicado: (2015)

Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer?
por: Suda, Kenichi
Publicado: (2019)

In search of the ideal basal insulin: Does the new‐generation ultra‐long‐acting insulin, degludec, provide the answer?
por: Hui, Elaine, et al.
Publicado: (2013)

TB or NTM: Can a new multiplex PCR assay be the answer?
por: Anand, Appakkudal R, et al.
Publicado: (2021)

Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
por: Kimura, Tomohiko, et al.
Publicado: (2022)

Is Brain Insulin Action Relevant to the Control of Plasma Glucose in Humans?
por: Edgerton, Dale S., et al.
Publicado: (2015)

Chewing the fat for better insulin secretion
por: Andrikopoulos, Sofianos
Publicado: (2015)

Role of clock genes in insulin secretion
por: Harada, Norio, et al.
Publicado: (2016)

Acute Administration of Unacylated Ghrelin Has No Effect on Basal or Stimulated Insulin Secretion in Healthy Humans
por: Tong, Jenny, et al.
Publicado: (2014)

Task shifting: the answer to the human resources crisis in Africa?
por: Lehmann, Uta, et al.
Publicado: (2009)

Marked Suppression of Ghrelin Concentration by Insulin in Prader-Willi Syndrome
por: Paik, Kyung-Hoon, et al.
Publicado: (2007)

Suppression of Ghrelin Exacerbates HFCS-Induced Adiposity and Insulin Resistance
por: Ma, Xiaojun, et al.
Publicado: (2017)

Ghrelin: A New Incretin Enhancer Therapy?
por: DeMarco, Vincent G., et al.
Publicado: (2015)

A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
por: Gahete, Manuel D., et al.
Publicado: (2011)

Hypothalamic Regulation of Glucose-Stimulated Insulin Secretion
por: Chan, Owen, et al.
Publicado: (2012)

TRP-ing Down the Path to Insulin Secretion
por: MacDonald, Patrick E.
Publicado: (2011)

Achieving “PeaK-A” Insulin Secretion
por: Evans-Molina, Carmella, et al.
Publicado: (2013)

When should we start renal-replacement therapy in critically ill patients with acute kidney injury: do we finally have the answer?
por: Bagshaw, Sean M., et al.
Publicado: (2021)

Is ghrelin a glucagon‐like peptide‐1 secretagogue?
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Emptying the Pool: Modular Insulin Secretion From the Pancreas
por: Rizzo, Mark A.
Publicado: (2016)

Peeling the onion: another layer in the regulation of insulin secretion
por: Aamodt, Kristie I., et al.
Publicado: (2023)

Five questions that need answering when considering the design of clinical trials
por: Clark, Timothy, et al.
Publicado: (2014)

Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R
por: Pradhan, Geetali, et al.
Publicado: (2017)

Improving clinical trial efficiency: Is technology the answer?
por: French, Jacqueline A.
Publicado: (2017)

Lawmakers Demand Answers From EPA
por: Ruediger, Nicole
Publicado: (2001)

Biosignatures: The answer to Tuberculosis diagnosis in children?
por: Goussard, Pierre, et al.
Publicado: (2020)

On time surgery start: Is standardization the answer?
por: Dada, Olufunke F., et al.
Publicado: (2022)

Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
por: MacIsaac, Richard J.
Publicado: (2020)

Frailty as a Clinically Relevant Measure of Human Aging
por: Jung, Hee-Won
Publicado: (2021)

Is fibrinogen the answer to coagulopathy after massive transfusions?
por: Tisherman, Samuel A
Publicado: (2010)

Post-conditioning: Promising answers and more questions
por: Bracco, David
Publicado: (2012)

Answering the question: are we making a difference?
por: Huntington, Dale
Publicado: (2013)

THU309 Ghrelin Deficiency Does Not Improve Glucose Tolerance And Insulin Secretion In Female Mice
por: Gupta, Deepali, et al.
Publicado: (2023)

Fractalkine signaling in regulation of insulin secretion: Mechanisms and potential therapeutic implications?
por: Gregg, Brigid, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q66cqi51cihejlkqk1fo8ncl3d